Gainers

• NextCure (NASDAQ:NXTC) stock increased by 201.4% to $6.57 during Tuesday's regular session. The market value of their outstanding shares is at $7.8 million.
• Shuttle Pharmaceuticals (NASDAQ:SHPH) shares rose 39.86% to $4.14. The company's market cap stands at $1.7 million.
• Galectin Therapeutics (NASDAQ:GALT) stock moved upwards by 19.13% to $5.48. The company's market cap stands at $302.9 million.
• BioXcel Therapeutics (NASDAQ:BTAI) shares rose 17.89% to $1.04. The market value of their outstanding shares is at $27.2 million.
• Actuate Therapeutics (NASDAQ:ACTU) shares increased by 17.66% to $1.76. The market value of their outstanding shares is at $35.8 million.
• Cibus (NASDAQ:CBUS) stock moved upwards by 17.37% to $2.5. The company's market cap stands at $162.5 million.

Losers

• Matinas BioPharma Hldgs (AMEX:MTNB) shares fell 32.1% to $0.33 during Tuesday's regular session. The market value of their outstanding shares is at $3.0 million.
• Z Squared (NASDAQ:ZSQR) shares decreased by 21.95% to $5.62. The company's market cap stands at $379.6 million.
• Spero Therapeutics (NASDAQ:SPRO) shares fell 19.72% to $1.75. The company's market cap stands at $126.2 million.
• Regentis Biomaterials (AMEX:RGNT) stock declined by 16.72% to $2.89. The market value of their outstanding shares is at $24.3 million.
• Carlsmed (NASDAQ:CARL) shares declined by 14.95% to $10.3. The company's market cap stands at $329.2 million.
• Valion Bio (NASDAQ:VBIO) stock declined by 14.49% to $0.43. The company's market cap stands at $1.6 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.